Vascular Closure Device Market Size, Share, Trends, Demand, Growth, Challenges and Competitive Outlook

kirti narayankar

posted on 3 hours ago — updated on 1 second ago

9
views

The global Vascular Closure Device market size was valued at USD 1.94 billion in 2024 and is projected to reach USD 3.16 billion by 2032, with a CAGR of 6.33% during the forecast period of 2025 to 2032.

"Vascular Closure Device Market - Overview, Size, Share, Industry Trends and Opportunities

Global Vascular Closure Device By Type (Passive Approximators, Active Approximators, and External Hemostatic Devices), Access (Femoral Access and Radial Access), Procedure (Interventional Cardiology, Interventional Radiology/ Vascular Surgery), Distribution Channel (Direct Tenders and Retail), Application (Diagnostic Intervention and Therapeutic Intervention), End User (Hospitals and Clinics, Specialty Centres, Ambulatory Surgery Centres and Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028

Access Full 350 Pages PDF Report @

https://www.databridgemarketresearch.com/reports/vascular-closure-device-market

**Segments**

- **Product Type**: The market is segmented based on product type into passive closure devices and active closure devices. Passive closure devices are expected to witness significant growth due to their ease of use and effectiveness in sealing vascular access sites.
- **Access**: The market is divided into femoral and radial access closure devices. Radial access closure devices are gaining traction as they offer reduced complications and quicker ambulation for patients post-procedure.
- **Application**: Based on application, the market is categorized into interventional cardiology and interventional radiology. The interventional cardiology segment dominates the market owing to the rising prevalence of cardiovascular diseases and the increasing adoption of minimally invasive procedures.
- **End-User**: The end-user segment includes hospitals, ambulatory surgical centers, and cardiac catheterization laboratories. Hospitals account for a significant share in the market due to the high volume of vascular closure procedures performed in these settings.

**Market Players**

- **Abbott**
- **Cardinal Health**
- **BD**
- **Cardiva Medical, Inc.**
- **Terumo Corporation**
- **Vascular Solutions, Inc.**
- **Essential Medical, Inc.**
- **Scion Biomedical**
- **Morrris Innovative**
- **TZ Medical, Inc.**

The global vascular closure device market is witnessing substantial growth driven by the increasing prevalence of cardiovascular diseases, technological advancements in closure devices, and the rising demand for minimally invasive procedures. The market is characterized by intense competition with key players focusing on product innovation, strategic collaborations, and geographical expansion to strengthen their market position. The adoption of vascular closure devices is expected to surge further with the growing preference for interventional procedures and the shift towards outpatient settings. North America dominates the market due to the high incidence of cardiovascular disorders and well-established healthcare infrastructure. However, the Asia Pacific region is anticipated to witness rapid growth attributed to the improving healthcare facilities and the rising healthcare expenditure in emerging economies. Overall, the global vascular closure device market is poised for significant expansion in the coming years.

https://www.databridgemarketresearch.com/reports/vascular-closure-device-marketThe global vascular closure device market is experiencing notable growth propelled by the escalating burden of cardiovascular diseases across the globe. As technological advancements continue to enhance the efficacy and safety of closure devices, the market is witnessing a surge in demand for minimally invasive procedures. Leading market players such as Abbott, Cardinal Health, BD, and others are actively engaged in pioneering product innovation to cater to the evolving needs of healthcare providers and patients. Strategic collaborations and geographical expansions are key strategies employed by these players to solidify their market presence and gain a competitive edge in the market landscape.

The increased preference for interventional procedures and the transition towards outpatient settings are driving the adoption of vascular closure devices. With a focus on enhancing patient outcomes and reducing recovery times, healthcare facilities are increasingly opting for these devices to ensure efficient post-procedural care. The interventional cardiology segment holds a significant share in the market, primarily due to the escalating prevalence of cardiovascular conditions and the growing acceptance of minimally invasive interventions among patients and healthcare professionals alike.

While North America currently leads the global market owing to the high incidence of cardiovascular disorders and well-developed healthcare infrastructure, the Asia Pacific region is poised for rapid growth. The improving healthcare amenities and the escalating healthcare expenditure in emerging economies are key factors contributing to the expansion of the market in this region. As awareness regarding the benefits of vascular closure devices continues to grow, coupled with the increasing emphasis on cost-effective and patient-friendly medical interventions, the market is set for substantial expansion in the foreseeable future.

The competitive landscape of the vascular closure device market is characterized by intense rivalry among key players striving to introduce cutting-edge solutions and differentiate their offerings. With a strong emphasis on technological advancements and strategic partnerships, market participants are working towards meeting the evolving needs of healthcare providers and enhancing patient care outcomes. Overall, the global vascular closure device market presents lucrative opportunities for growth and innovation, with a focus on addressing the growing demand for minimally invasive procedures and advancing patient care practices in the cardiovascular space.**Segments**
- Global Vascular Closure Device By Type (Passive Approximators, Active Approximators, and External Hemostatic Devices)
- Access (Femoral Access and Radial Access)
- Procedure (Interventional Cardiology, Interventional Radiology/ Vascular Surgery)
- Distribution Channel (Direct Tenders and Retail)
- Application (Diagnostic Intervention and Therapeutic Intervention)
- End User (Hospitals and Clinics, Specialty Centres, Ambulatory Surgery Centres and Others)
- Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028

The global vascular closure device market is witnessing robust growth driven by factors such as the increasing burden of cardiovascular diseases worldwide, advancements in technology enhancing closure devices, and the growing demand for minimally invasive procedures. In terms of product type, both passive and active closure devices are gaining traction, with passive devices being preferred for their ease of use and effectiveness in sealing vascular access sites. The access segment is divided into femoral and radial access closure devices, with radial access devices seeing increased adoption due to reduced complications and faster post-procedural ambulation for patients.

The market is further segmented by application, with interventional cardiology leading the way due to the rising prevalence of cardiovascular conditions and the uptick in minimally invasive procedures. End-users primarily include hospitals, ambulatory surgical centers, and cardiac catheterization laboratories, with hospitals holding a substantial market share due to the high volume of vascular closure procedures performed in these settings. Geographically, North America currently dominates the market, driven by a high incidence of cardiovascular disorders and well-established healthcare infrastructure. However, the Asia Pacific region is forecasted to witness rapid growth, fueled by improving healthcare facilities and increased healthcare expenditure in emerging economies.

In terms of market players, key companies such as Abbott, Cardinal Health, BD, and others are focusing on product innovation, strategic collaborations, and expanding their geographical footprint to strengthen their market position. The emphasis on enhancing patient outcomes, reducing recovery times, and the trend towards outpatient settings are driving the adoption of vascular closure devices across various healthcare facilities. The competitive landscape is fierce, with players competing through technological advancements and partnerships to meet the evolving needs of healthcare providers and improve patient care outcomes.

As the awareness of the benefits of vascular closure devices grows and the focus on cost-effective and patient-friendly medical interventions intensifies, the global vascular closure device market is set for significant expansion in the near future. With a continued emphasis on minimally invasive procedures, advancing patient care practices, and addressing the demand for innovative solutions, the market presents lucrative opportunities for growth and innovation. The industry outlook points towards a trajectory of continuous evolution and adaptation to meet the changing landscape of cardiovascular care.

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the Vascular Closure Device Market.
Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.
Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.
Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies.
Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Vascular Closure Device Market.

Table of Content:

Part 01: Executive Summary

Part 02: Scope of the Report

Part 03: Global Vascular Closure Device Market Landscape

Part 04: Global Vascular Closure Device Market Sizing

Part 05: Global Vascular Closure Device Market Segmentation by Product

Part 06: Five Forces Analysis

Part 07: Customer Landscape

Part 08: Geographic Landscape

Part 09: Decision Framework

Part 10: Drivers and Challenges

Part 11: Market Trends

Part 12: Vendor Landscape

Part 13: Vendor Analysis

This study answers to the below key questions:

What are the key factors driving the Vascular Closure Device Market?
What are the challenges to market growth?
Who are the key players in the Vascular Closure Device Market?
What are the market opportunities and threats faced by the key players?

Browse Trending Reports:

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact Us:

Data Bridge Market Research

US: +1 614 591 3140

UK: +44 845 154 9652

APAC : +653 1251 975

Email: corporatesales@databridgemarketresearch.com"